The Asia Pacific Atrial Fibrillation Market would witness market growth of 7.0% CAGR during the forecast period (2022-2028).
The majority of occurrences of AF are due to other medical conditions, an underlying cause may be present if there is chest discomfort or angina, hyperthyroidism (an overactive thyroid gland) symptoms including weight loss and diarrhea, or lung disease symptoms. Someone with AF may be more susceptible to problems if they have a history of heart failure, high blood pressure, rheumatic fever, diabetes, or a stroke or transient ischemic attack (TIA).
Similar to other types of fast heart rate, the presentation may be asymptomatic. Chest pain and palpitations are frequent symptoms. Rapid, uncoordinated heartbeats can limit cardiac output, or how much blood the heart pumps, which can lead to insufficient blood flow and, ultimately, insufficient oxygenation of the body's other tissues.
Breathlessness, breathlessness while lying flat, disorientation, and abrupt onset of breathlessness throughout the night are common signs of uncontrolled atrial fibrillation. Lower extremity edema, a sign of congestive heart failure, might develop as a result. People with AF may also experience lightheadedness as a result of low cardiac output.
Atrial Fibrillation can lead to respiratory discomfort because of lung congestion. The heart rate will, by definition, be higher than 100 beats per minute. Blood pressure may vary and is frequently challenging to measure since the majority of digital (oscillometric) non-invasive blood pressure monitors have issues with beat-by-beat fluctuation.
The lifestyle of the general populace in China has changed dramatically as a result of socioeconomic progress. People are exposed to cardiovascular-related risk factors more often as a result of population aging and urbanization in China, which has resulted in a rise in the incidence and prevalence of cardiovascular disease (CVD) during the previous ten years. The 2018 study on CVDs in China stated that there were around 290 million cardiovascular patients in the country, of whom 13 million had strokes and 11 million had coronary heart disease.
The China market dominated the Asia Pacific Atrial Fibrillation Market by Country in 2021; thereby, achieving a market value of $228.9 million by 2028. The Japan market is exhibiting a CAGR of 6.3% during (2022 - 2028). Additionally, The India market would experience a CAGR of 7.6% during (2022 - 2028).
Based on End User, the market is segmented into Hospitals, Specialty Clinics, and Others. Based on Type, the market is segmented into Surgical and Non-Surgical. Based on Technology, the market is segmented into Radiofrequency, Laser, Cryotherapy, and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
Free Valuable Insights: The Worldwide Atrial Fibrillation Market is Projected to reach USD 2.7 Billion by 2028, at a CAGR of 9.5%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Johnson & Johnson, MicroPort Scientific Corporation, Boston Scientific Corporation, Abbott Laboratories, Medtronic PLC, BIOTRONIK SE & Co. KG, Koninklijke Philips N.V., Siemens Healthineers AG (Siemens AG) and AtriCure, Inc.
Scope of the Study
Market Segments Covered in the Report:
By End User
- Hospitals
- Specialty Clinics
- Others
By Type
By Technology
- Radiofrequency
- Laser
- Cryotherapy
- Others
By Country
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
Key Market Players
List of Companies Profiled in the Report:
- Johnson & Johnson
- MicroPort Scientific Corporation
- Boston Scientific Corporation
- Abbott Laboratories
- Medtronic PLC
- BIOTRONIK SE & Co. KG
- Koninklijke Philips N.V.
- Siemens Healthineers AG (Siemens AG)
- AtriCure, Inc.
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Atrial Fibrillation Market, by End User
1.4.2 Asia Pacific Atrial Fibrillation Market, by Type
1.4.3 Asia Pacific Atrial Fibrillation Market, by Technology
1.4.4 Asia Pacific Atrial Fibrillation Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenarios
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.2.4 Approvals and Trials
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)
3.3.2 Key Strategic Move: (Acquisitions and Mergers: 2018, Jun – 2022, Jan) Leading Players
Chapter 4. Asia Pacific Atrial Fibrillation Market by End User
4.1 Asia Pacific Hospitals Market by Country
4.2 Asia Pacific Specialty Clinics Market by Country
4.3 Asia Pacific Others Market by Country
Chapter 5. Asia Pacific Atrial Fibrillation Market by Type
5.1 Asia Pacific Surgical Market by Country
5.2 Asia Pacific Non-Surgical Market by Country
Chapter 6. Asia Pacific Atrial Fibrillation Market by Technology
6.1 Asia Pacific Radiofrequency Market by Country
6.2 Asia Pacific Laser Market by Country
6.3 Asia Pacific Cryotherapy Market by Country
6.4 Asia Pacific Others Market by Country
Chapter 7. Asia Pacific Atrial Fibrillation Market by Country
7.1 China Atrial Fibrillation Market
7.1.1 China Atrial Fibrillation Market by End User
7.1.2 China Atrial Fibrillation Market by Type
7.1.3 China Atrial Fibrillation Market by Technology
7.2 Japan Atrial Fibrillation Market
7.2.1 Japan Atrial Fibrillation Market by End User
7.2.2 Japan Atrial Fibrillation Market by Type
7.2.3 Japan Atrial Fibrillation Market by Technology
7.3 India Atrial Fibrillation Market
7.3.1 India Atrial Fibrillation Market by End User
7.3.2 India Atrial Fibrillation Market by Type
7.3.3 India Atrial Fibrillation Market by Technology
7.4 South Korea Atrial Fibrillation Market
7.4.1 South Korea Atrial Fibrillation Market by End User
7.4.2 South Korea Atrial Fibrillation Market by Type
7.4.3 South Korea Atrial Fibrillation Market by Technology
7.5 Singapore Atrial Fibrillation Market
7.5.1 Singapore Atrial Fibrillation Market by End User
7.5.2 Singapore Atrial Fibrillation Market by Type
7.5.3 Singapore Atrial Fibrillation Market by Technology
7.6 Malaysia Atrial Fibrillation Market
7.6.1 Malaysia Atrial Fibrillation Market by End User
7.6.2 Malaysia Atrial Fibrillation Market by Type
7.6.3 Malaysia Atrial Fibrillation Market by Technology
7.7 Rest of Asia Pacific Atrial Fibrillation Market
7.7.1 Rest of Asia Pacific Atrial Fibrillation Market by End User
7.7.2 Rest of Asia Pacific Atrial Fibrillation Market by Type
7.7.3 Rest of Asia Pacific Atrial Fibrillation Market by Technology
Chapter 8. Company Profiles
8.1 Johnson & Johnson
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental &Regional Analysis
8.1.4 Research & Development Expenses
8.2 MicroPort Scientific Corporation
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expense
8.2.5 Recent strategies and developments:
8.2.5.1 Partnerships, Collaborations, and Agreements:
8.2.5.2 Product Launches and Product Expansions:
8.2.5.3 Approvals and Trials:
8.3 Medtronic PLC
8.3.1 Company overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expenses
8.3.5 Recent strategies and developments:
8.3.5.1 Product Launches and Product Expansions:
8.3.5.2 Acquisition and Mergers:
8.3.6 SWOT Analysis
8.4 Boston Scientific Corporation
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research & Development Expense
8.4.5 Recent strategies and developments:
8.4.5.1 Product Launches and Product Expansions:
8.4.5.2 Acquisition and Mergers:
8.4.5.3 Approvals and Trials:
8.4.6 SWOT Analysis
8.5 BIOTRONIK SE & Co. KG
8.5.1 Company Overview
8.5.2 Recent strategies and developments:
8.5.2.1 Approvals and Trials:
8.6 Abbott Laboratories
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental and Regional Analysis
8.6.4 Research & Development Expense
8.6.5 Recent strategies and developments:
8.6.5.1 Product Launches and Product Expansions:
8.6.5.2 Approvals and Trials:
8.6.6 SWOT Analysis
8.7 Koninklijke Philips N.V.
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental and Regional Analysis
8.7.4 Research & Development Expense
8.7.5 Recent strategies and developments:
8.7.5.1 Partnerships, Collaborations, and Agreements:
8.7.5.2 Acquisition and Mergers:
8.7.5.3 Geographical Expansions:
8.8 Siemens Healthineers AG (Siemens AG)
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Segmental and Regional Analysis
8.8.4 Research & Development Expense
8.8.5 Recent strategies and developments:
8.8.5.1 Product Launches and Product Expansions:
8.8.5.2 Acquisition and Mergers:
8.8.6 SWOT Analysis
8.9 AtriCure, Inc.
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Regional Analysis
8.9.4 Research & Development Expenses
8.9.5 Recent strategies and developments:
8.9.5.1 Product Launches and Product Expansions:
8.9.5.2 Acquisition and Mergers:
8.9.5.3 Approvals and Trials:
TABLE 1 Asia Pacific Atrial Fibrillation Market, 2018 - 2021, USD Million
TABLE 2 Asia Pacific Atrial Fibrillation Market, 2022 - 2028, USD Million
TABLE 3 Partnerships, Collaborations and Agreements – Atrial Fibrillation Market
TABLE 4 Product Launches And Product Expansions – Atrial Fibrillation Market
TABLE 5 Acquisition and Mergers – Atrial Fibrillation Market
TABLE 6 Approvals and Trials – Atrial Fibrillation Market
TABLE 7 Asia Pacific Atrial Fibrillation Market by End User, 2018 - 2021, USD Million
TABLE 8 Asia Pacific Atrial Fibrillation Market by End User, 2022 - 2028, USD Million
TABLE 9 Asia Pacific Hospitals Market by Country, 2018 - 2021, USD Million
TABLE 10 Asia Pacific Hospitals Market by Country, 2022 - 2028, USD Million
TABLE 11 Asia Pacific Specialty Clinics Market by Country, 2018 - 2021, USD Million
TABLE 12 Asia Pacific Specialty Clinics Market by Country, 2022 - 2028, USD Million
TABLE 13 Asia Pacific Others Market by Country, 2018 - 2021, USD Million
TABLE 14 Asia Pacific Others Market by Country, 2022 - 2028, USD Million
TABLE 15 Asia Pacific Atrial Fibrillation Market by Type, 2018 - 2021, USD Million
TABLE 16 Asia Pacific Atrial Fibrillation Market by Type, 2022 - 2028, USD Million
TABLE 17 Asia Pacific Surgical Market by Country, 2018 - 2021, USD Million
TABLE 18 Asia Pacific Surgical Market by Country, 2022 - 2028, USD Million
TABLE 19 Asia Pacific Non-Surgical Market by Country, 2018 - 2021, USD Million
TABLE 20 Asia Pacific Non-Surgical Market by Country, 2022 - 2028, USD Million
TABLE 21 Asia Pacific Atrial Fibrillation Market by Technology, 2018 - 2021, USD Million
TABLE 22 Asia Pacific Atrial Fibrillation Market by Technology, 2022 - 2028, USD Million
TABLE 23 Asia Pacific Radiofrequency Market by Country, 2018 - 2021, USD Million
TABLE 24 Asia Pacific Radiofrequency Market by Country, 2022 - 2028, USD Million
TABLE 25 Asia Pacific Laser Market by Country, 2018 - 2021, USD Million
TABLE 26 Asia Pacific Laser Market by Country, 2022 - 2028, USD Million
TABLE 27 Asia Pacific Cryotherapy Market by Country, 2018 - 2021, USD Million
TABLE 28 Asia Pacific Cryotherapy Market by Country, 2022 - 2028, USD Million
TABLE 29 Asia Pacific Others Market by Country, 2018 - 2021, USD Million
TABLE 30 Asia Pacific Others Market by Country, 2022 - 2028, USD Million
TABLE 31 Asia Pacific Atrial Fibrillation Market by Country, 2018 - 2021, USD Million
TABLE 32 Asia Pacific Atrial Fibrillation Market by Country, 2022 - 2028, USD Million
TABLE 33 China Atrial Fibrillation Market, 2018 - 2021, USD Million
TABLE 34 China Atrial Fibrillation Market, 2022 - 2028, USD Million
TABLE 35 China Atrial Fibrillation Market by End User, 2018 - 2021, USD Million
TABLE 36 China Atrial Fibrillation Market by End User, 2022 - 2028, USD Million
TABLE 37 China Atrial Fibrillation Market by Type, 2018 - 2021, USD Million
TABLE 38 China Atrial Fibrillation Market by Type, 2022 - 2028, USD Million
TABLE 39 China Atrial Fibrillation Market by Technology, 2018 - 2021, USD Million
TABLE 40 China Atrial Fibrillation Market by Technology, 2022 - 2028, USD Million
TABLE 41 Japan Atrial Fibrillation Market, 2018 - 2021, USD Million
TABLE 42 Japan Atrial Fibrillation Market, 2022 - 2028, USD Million
TABLE 43 Japan Atrial Fibrillation Market by End User, 2018 - 2021, USD Million
TABLE 44 Japan Atrial Fibrillation Market by End User, 2022 - 2028, USD Million
TABLE 45 Japan Atrial Fibrillation Market by Type, 2018 - 2021, USD Million
TABLE 46 Japan Atrial Fibrillation Market by Type, 2022 - 2028, USD Million
TABLE 47 Japan Atrial Fibrillation Market by Technology, 2018 - 2021, USD Million
TABLE 48 Japan Atrial Fibrillation Market by Technology, 2022 - 2028, USD Million
TABLE 49 India Atrial Fibrillation Market, 2018 - 2021, USD Million
TABLE 50 India Atrial Fibrillation Market, 2022 - 2028, USD Million
TABLE 51 India Atrial Fibrillation Market by End User, 2018 - 2021, USD Million
TABLE 52 India Atrial Fibrillation Market by End User, 2022 - 2028, USD Million
TABLE 53 India Atrial Fibrillation Market by Type, 2018 - 2021, USD Million
TABLE 54 India Atrial Fibrillation Market by Type, 2022 - 2028, USD Million
TABLE 55 India Atrial Fibrillation Market by Technology, 2018 - 2021, USD Million
TABLE 56 India Atrial Fibrillation Market by Technology, 2022 - 2028, USD Million
TABLE 57 South Korea Atrial Fibrillation Market, 2018 - 2021, USD Million
TABLE 58 South Korea Atrial Fibrillation Market, 2022 - 2028, USD Million
TABLE 59 South Korea Atrial Fibrillation Market by End User, 2018 - 2021, USD Million
TABLE 60 South Korea Atrial Fibrillation Market by End User, 2022 - 2028, USD Million
TABLE 61 South Korea Atrial Fibrillation Market by Type, 2018 - 2021, USD Million
TABLE 62 South Korea Atrial Fibrillation Market by Type, 2022 - 2028, USD Million
TABLE 63 South Korea Atrial Fibrillation Market by Technology, 2018 - 2021, USD Million
TABLE 64 South Korea Atrial Fibrillation Market by Technology, 2022 - 2028, USD Million
TABLE 65 Singapore Atrial Fibrillation Market, 2018 - 2021, USD Million
TABLE 66 Singapore Atrial Fibrillation Market, 2022 - 2028, USD Million
TABLE 67 Singapore Atrial Fibrillation Market by End User, 2018 - 2021, USD Million
TABLE 68 Singapore Atrial Fibrillation Market by End User, 2022 - 2028, USD Million
TABLE 69 Singapore Atrial Fibrillation Market by Type, 2018 - 2021, USD Million
TABLE 70 Singapore Atrial Fibrillation Market by Type, 2022 - 2028, USD Million
TABLE 71 Singapore Atrial Fibrillation Market by Technology, 2018 - 2021, USD Million
TABLE 72 Singapore Atrial Fibrillation Market by Technology, 2022 - 2028, USD Million
TABLE 73 Malaysia Atrial Fibrillation Market, 2018 - 2021, USD Million
TABLE 74 Malaysia Atrial Fibrillation Market, 2022 - 2028, USD Million
TABLE 75 Malaysia Atrial Fibrillation Market by End User, 2018 - 2021, USD Million
TABLE 76 Malaysia Atrial Fibrillation Market by End User, 2022 - 2028, USD Million
TABLE 77 Malaysia Atrial Fibrillation Market by Type, 2018 - 2021, USD Million
TABLE 78 Malaysia Atrial Fibrillation Market by Type, 2022 - 2028, USD Million
TABLE 79 Malaysia Atrial Fibrillation Market by Technology, 2018 - 2021, USD Million
TABLE 80 Malaysia Atrial Fibrillation Market by Technology, 2022 - 2028, USD Million
TABLE 81 Rest of Asia Pacific Atrial Fibrillation Market, 2018 - 2021, USD Million
TABLE 82 Rest of Asia Pacific Atrial Fibrillation Market, 2022 - 2028, USD Million
TABLE 83 Rest of Asia Pacific Atrial Fibrillation Market by End User, 2018 - 2021, USD Million
TABLE 84 Rest of Asia Pacific Atrial Fibrillation Market by End User, 2022 - 2028, USD Million
TABLE 85 Rest of Asia Pacific Atrial Fibrillation Market by Type, 2018 - 2021, USD Million
TABLE 86 Rest of Asia Pacific Atrial Fibrillation Market by Type, 2022 - 2028, USD Million
TABLE 87 Rest of Asia Pacific Atrial Fibrillation Market by Technology, 2018 - 2021, USD Million
TABLE 88 Rest of Asia Pacific Atrial Fibrillation Market by Technology, 2022 - 2028, USD Million
TABLE 89 Key information – Johnson & Johnson
TABLE 90 key Information – MicroPort Scientific Corporation
TABLE 91 Key Information – Medtronic PLC
TABLE 92 key Information – Boston Scientific Corporation
TABLE 93 Key Information – BIOTRONIK SE & Co. KG
TABLE 94 Key Information – Abbott Laboratories
TABLE 95 Key Information – Koninklijke Philips N.V.
TABLE 96 Key Information – Siemens Healthineers AG
TABLE 97 Key Information – AtriCure, Inc.
List of Figures
FIG 1 Methodology for the research
FIG 2 KBV Cardinal Matrix
FIG 3 Key Leading Strategies: Percentage Distribution (2018-2022)
FIG 4 Key Strategic Move: (Acquisitions and Mergers: 2018, Jun – 2022, Jan) Leading Players
FIG 5 Recent strategies and developments: MicroPort Scientific Corporation
FIG 6 Swot analysis: Medtronic plc
FIG 7 Recent strategies and developments: Boston Scientific Corporation
FIG 8 SWOT Analysis: Boston Scientific Corporation
FIG 9 Swot analysis: Abbott laboratories
FIG 10 Recent strategies and developments: Koninklijke Philips N.V.
FIG 11 Recent strategies and developments: Siemens Healthineers AG
FIG 12 Swot analysis: Siemens AG
FIG 13 Recent strategies and developments: AtriCure, Inc.